{"id":2698,"date":"2022-09-01T00:01:00","date_gmt":"2022-09-01T04:01:00","guid":{"rendered":"https:\/\/www.cannara.ca\/?p=2698"},"modified":"2026-04-07T02:00:21","modified_gmt":"2026-04-07T06:00:21","slug":"cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41","status":"publish","type":"post","link":"https:\/\/www.cannara.ca\/fr\/2022\/09\/01\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\/","title":{"rendered":"Acquisition d&rsquo;Actions Ordinaires de Cannara Biotech Inc."},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong><em>MONTREAL, QU\u00c9BEC \u2013 <\/em><\/strong>01 sept, 2022\u2013 <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=fr&amp;o=3636546-1&amp;h=1299719826&amp;u=https%3A%2F%2Fwww.cannara.ca%2Fen%2F&amp;a=Cannara%C2%A0Biotech%C2%A0Inc.\" rel=\"noreferrer noopener\" target=\"_blank\">Cannara&nbsp;Biotech&nbsp;Inc.<\/a>&nbsp;(<strong>\u00ab&nbsp;Cannara<\/strong>&nbsp;<strong>\u00bb<\/strong>&nbsp;ou la&nbsp;<strong>\u00ab&nbsp;Soci\u00e9t\u00e9<\/strong>&nbsp;<strong>\u00bb<\/strong>) (TSXV:&nbsp;<a href=\"https:\/\/www.newswire.ca\/fr\/news-releases\/acquisition-d-actions-ordinaires-de-cannara-biotech-inc--832064777.html#financial-modal\">LOVE<\/a>) (OTCQB: LOVFF) (FRA: 8CB), un producteur verticalement int\u00e9gr\u00e9 de cannabis et de produits d\u00e9riv\u00e9s de qualit\u00e9 sup\u00e9rieure qui poss\u00e8de l&rsquo;une des plus grandes installations pour la culture de cannabis int\u00e9rieure au&nbsp;Canada&nbsp;et la plus grande au Qu\u00e9bec, a annonc\u00e9 que le 31 ao\u00fbt 2022,&nbsp;Derek Stern, un administrateur et actionnaire principal d\u00e9tenant plus de 10&nbsp;% des actions ordinaires \u00e9mises en circulation (\u00ab&nbsp;<strong>Actions Ordinaires<\/strong>&nbsp;\u00bb), de Cannara, a acquis 720 000 actions ordinaires (les \u00ab&nbsp;<strong>Actions Achet\u00e9es&nbsp;<\/strong>\u00bb) du capital de Cannara repr\u00e9sentant environ 0,08 % des Actions Ordinaires du capital de la Soci\u00e9t\u00e9 (l&rsquo;\u00ab&nbsp;<strong>Acquisition&nbsp;<\/strong>\u00bb).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Les Actions Achet\u00e9es ont \u00e9t\u00e9 acquises par un achat dans le cours normal des activit\u00e9s par l&rsquo;interm\u00e9diaire de la Bourse de croissance TSX pour 0,112 $ dollars canadien par Action Achet\u00e9es, pour un montant total de 80 285$ dollars canadien.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Avant l&rsquo;Acquisition, M. Stern, par le biais de participations majoritaires dans Investissements Olymbec Inc., d\u00e9tenait directement et indirectement 163 650 184 Actions Ordinaires et 100 000 options d&rsquo;achat d&rsquo;actions ordinaires (\u00ab<strong>&nbsp;Options&nbsp;<\/strong>\u00bb), repr\u00e9sentant environ 18,66 % des Actions Ordinaires \u00e9mises et en circulation sur une base partiellement dilu\u00e9e. Apr\u00e8s l&rsquo;Acquisition, M. Stern, par le biais de participations majoritaires dans Investissements Olymbec Inc., d\u00e9tient directement et indirectement 164 370 184 Actions Ordinaires et 100 000 Options, repr\u00e9sentant environ 18,74 % des Actions Ordinaires \u00e9mises et en circulation sur une base partiellement dilu\u00e9e.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">M. Stern a acquis les Actions Achet\u00e9es \u00e0 des fins d&rsquo;investissement. Il est possible que&nbsp;M. Stern acqui\u00e8re de temps en temps des titres suppl\u00e9mentaires de la Soci\u00e9t\u00e9, dispose en tout ou en partie des titres existants ou suppl\u00e9mentaires ou continue de d\u00e9tenir les titres.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ce communiqu\u00e9 de presse est publi\u00e9 conform\u00e9ment \u00e0 la \u00ab National Instrument 62-103 &#8211;<em>The Early Warning System and Related Take-Over Bid and Insider Reporting Issuer&nbsp;<\/em>\u00bb. Une copie de la d\u00e9claration d&rsquo;alerte connexe est en cours de d\u00e9p\u00f4t aupr\u00e8s des commissions des valeurs mobili\u00e8res comp\u00e9tentes et sera disponible sous le profil de la Soci\u00e9t\u00e9 sur SEDAR (<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=fr&amp;o=3636546-1&amp;h=755161198&amp;u=http%3A%2F%2Fwww.sedar.com%2F&amp;a=www.sedar.com\" rel=\"noreferrer noopener\" target=\"_blank\">www.sedar.com<\/a>). Le si\u00e8ge social de Cannara est situ\u00e9 au 333 boul. D\u00e9carie, suite 200, Montr\u00e9al, Qu\u00e9bec, H4N 3M9. L&rsquo;adresse principale du bureau de M. Stern est le 333, boul. D\u00e9carie, suite 500, Montr\u00e9al, Qu\u00e9bec H4N 3M9.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\">CONTACT<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Nicholas Sosiak, CPA, CA<br>Chef de la direction financi\u00e8re<br><a href=\"mailto:nick@cannara.ca\">nick@cannara.ca<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Zohar Krivorot<br>Fondateur et PDG<br><a href=\"mailto:zohar@cannara.ca\">zohar@cannara.ca<\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\">\u00c0 PROPOS DE CANNARA BIOTECH INC.<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=fr&amp;o=3521785-1&amp;h=2770184140&amp;u=http%3A%2F%2Fwww.cannara.ca%2F&amp;a=Cannara+Biotech+Inc.\" rel=\"noreferrer noopener\" target=\"_blank\">Cannara Biotech Inc.<\/a>&nbsp;(<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=fr&amp;o=3521785-1&amp;h=2606233419&amp;u=https%3A%2F%2Fmoney.tmx.com%2Fen%2Fquote%2FLOVE&amp;a=TSXV%3A+LOVE\" rel=\"noreferrer noopener\" target=\"_blank\">TSXV:&nbsp;<\/a><a href=\"https:\/\/www.newswire.ca\/fr\/news-releases\/cannara-biotech-inc-fera-une-presentation-a-la-6e-conference-annuelle-sur-le-cannabis-de-canaccord-genuity-le-11-mai-et-retient-les-services-de-bristol-capital-pour-les-relations-avec-les-investisseurs-853422620.html#financial-modal\">LOVE<\/a>) (<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=fr&amp;o=3521785-1&amp;h=2083158435&amp;u=https%3A%2F%2Fwww.otcmarkets.com%2Fstock%2FLOVFF%2Fnews%3Fid%3D300332&amp;a=OTCQB%3A+LOVFF\" rel=\"noreferrer noopener\" target=\"_blank\">OTCQB: LOVFF<\/a>) (<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=fr&amp;o=3521785-1&amp;h=130754712&amp;u=https%3A%2F%2Fwww.boerse-frankfurt.de%2Fequity%2Fcannara-biotech-inc&amp;a=FRA%3A+8CB\" rel=\"noreferrer noopener\" target=\"_blank\">FRA: 8CB<\/a>) est un producteur verticalement int\u00e9gr\u00e9 de cannabis cultiv\u00e9 \u00e0 l&rsquo;int\u00e9rieur et de produits d\u00e9riv\u00e9s du cannabis de qualit\u00e9 sup\u00e9rieure destin\u00e9s aux march\u00e9s qu\u00e9b\u00e9cois et canadien. Cannara poss\u00e8de deux m\u00e9ga-installations situ\u00e9es au Qu\u00e9bec, qui s&rsquo;\u00e9tendent sur plus de 1 650 000 pieds carr\u00e9s et qui repr\u00e9sentent un potentiel de culture annuelle de 125 000 kg. Tirant parti des faibles co\u00fbts d&rsquo;\u00e9lectricit\u00e9 du Qu\u00e9bec, les installations de Cannara cr\u00e9ent des produits de cannabis de premi\u00e8re qualit\u00e9 cultiv\u00e9s avec soin, et ce, \u00e0 prix abordable. Pour obtenir de plus amples renseignements, visitez le site&nbsp;<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=fr&amp;o=3521785-1&amp;h=3002142611&amp;u=http%3A%2F%2Fwww.cannara.ca%2F&amp;a=cannara.ca\" rel=\"noreferrer noopener\" target=\"_blank\">cannara.ca<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><em>La Bourse de croissance TSX et son fournisseur de services de r\u00e9glementation (au sens attribu\u00e9 \u00e0 ce terme dans les politiques de la Bourse de croissance TSX) n&rsquo;assument aucune responsabilit\u00e9 quant \u00e0 la pertinence ou \u00e0 l&rsquo;exactitude du pr\u00e9sent communiqu\u00e9.<\/em><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Mise en garde concernant les \u00ab&nbsp;renseignements prospectifs&nbsp;\u00bb<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Le pr\u00e9sent communiqu\u00e9 contient certains renseignements prospectifs. De tels renseignements comportent des risques connus et inconnus, des incertitudes et d&rsquo;autres facteurs qui pourraient faire en sorte que les r\u00e9sultats, les rendements ou les r\u00e9alisations r\u00e9els divergent substantiellement de ceux sous-entendus dans les \u00e9nonc\u00e9s aux pr\u00e9sentes. Donc, ces \u00e9nonc\u00e9s ne devraient pas \u00eatre per\u00e7us comme des garanties de rendements ou r\u00e9sultats futurs. Tous les \u00e9nonc\u00e9s prospectifs sont fond\u00e9s sur les croyances actuelles de l&rsquo;entreprise, sur ses suppositions et sur les renseignements actuellement disponibles, ainsi que sur d&rsquo;autres facteurs. Les lecteurs sont pri\u00e9s de ne pas se fier ind\u00fbment \u00e0 ces \u00e9nonc\u00e9s prospectifs, qui ne sont pertinents qu&rsquo;\u00e0 la date de ce communiqu\u00e9 de presse. En raison des risques et des incertitudes, incluant ceux identifi\u00e9s par l&rsquo;entreprise dans ses documents publics d\u00e9pos\u00e9s, les \u00e9v\u00e9nements r\u00e9els peuvent diff\u00e9rer de fa\u00e7on consid\u00e9rable des attentes actuelles. L&rsquo;entreprise n&rsquo;assume aucune obligation ou intention quant \u00e0 la mise \u00e0 jour ou \u00e0 la r\u00e9vision des \u00e9nonc\u00e9s prospectifs, que ce soit \u00e0 la lumi\u00e8re de nouvelles informations, d&rsquo;\u00e9v\u00e9nements futurs ou d&rsquo;autres \u00e9l\u00e9ments.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>MONTREAL, QU\u00c9BEC \u2013 01 sept, 2022\u2013 Cannara&nbsp;Biotech&nbsp;Inc.&nbsp;(\u00ab&nbsp;Cannara&nbsp;\u00bb&nbsp;ou la&nbsp;\u00ab&nbsp;Soci\u00e9t\u00e9&nbsp;\u00bb) (TSXV:&nbsp;LOVE) (OTCQB: LOVFF) (FRA: 8CB), un producteur verticalement int\u00e9gr\u00e9 de cannabis et de produits d\u00e9riv\u00e9s de qualit\u00e9 sup\u00e9rieure qui poss\u00e8de l&rsquo;une des plus grandes installations pour la culture de cannabis int\u00e9rieure au&nbsp;Canada&nbsp;et la plus grande au Qu\u00e9bec, a annonc\u00e9 que le 31 ao\u00fbt 2022,&nbsp;Derek Stern, un administrateur [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":"","_wpscp_schedule_draft_date":"","_wpscp_schedule_republish_date":"","_wpscppro_advance_schedule":false,"_wpscppro_advance_schedule_date":"","_wpscppro_dont_share_socialmedia":false,"_wpscppro_custom_social_share_image":0,"_facebook_share_type":"default","_twitter_share_type":"default","_linkedin_share_type":"default","_pinterest_share_type":"default","_linkedin_share_type_page":"default","_instagram_share_type":"default","_medium_share_type":"default","_threads_share_type":"default","_google_business_share_type":"default","_selected_social_profile":[],"_wpsp_enable_custom_social_template":false,"_wpsp_social_scheduling":{"enabled":false,"datetime":null,"platforms":[],"status":"template_only","dateOption":"today","timeOption":"now","customDays":"","customHours":"","customDate":"","customTime":"","schedulingType":"absolute"},"_wpsp_active_default_template":true},"categories":[30],"tags":[],"class_list":["post-2698","post","type-post","status-publish","format-standard","hentry","category-communiques-de-presse"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Acquisition d&#039;Actions Ordinaires de Cannara Biotech Inc. - Cannara Biotech<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cannara.ca\/fr\/2022\/09\/01\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acquisition d&#039;Actions Ordinaires de Cannara Biotech Inc. - Cannara Biotech\" \/>\n<meta property=\"og:description\" content=\"MONTREAL, QU\u00c9BEC \u2013 01 sept, 2022\u2013 Cannara&nbsp;Biotech&nbsp;Inc.&nbsp;(\u00ab&nbsp;Cannara&nbsp;\u00bb&nbsp;ou la&nbsp;\u00ab&nbsp;Soci\u00e9t\u00e9&nbsp;\u00bb) (TSXV:&nbsp;LOVE) (OTCQB: LOVFF) (FRA: 8CB), un producteur verticalement int\u00e9gr\u00e9 de cannabis et de produits d\u00e9riv\u00e9s de qualit\u00e9 sup\u00e9rieure qui poss\u00e8de l&rsquo;une des plus grandes installations pour la culture de cannabis int\u00e9rieure au&nbsp;Canada&nbsp;et la plus grande au Qu\u00e9bec, a annonc\u00e9 que le 31 ao\u00fbt 2022,&nbsp;Derek Stern, un administrateur [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cannara.ca\/fr\/2022\/09\/01\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\/\" \/>\n<meta property=\"og:site_name\" content=\"Cannara Biotech\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-01T04:01:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-07T06:00:21+00:00\" \/>\n<meta name=\"author\" content=\"cannaraadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"cannaraadmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2022\\\/09\\\/01\\\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2022\\\/09\\\/01\\\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\\\/\"},\"author\":{\"name\":\"cannaraadmin\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#\\\/schema\\\/person\\\/3aaaabd90bd805cac77b57ae47bf0f91\"},\"headline\":\"Acquisition d&rsquo;Actions Ordinaires de Cannara Biotech Inc.\",\"datePublished\":\"2022-09-01T04:01:00+00:00\",\"dateModified\":\"2026-04-07T06:00:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2022\\\/09\\\/01\\\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\\\/\"},\"wordCount\":830,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#organization\"},\"articleSection\":[\"Communiqu\u00e9s de presse\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2022\\\/09\\\/01\\\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\\\/\",\"url\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2022\\\/09\\\/01\\\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\\\/\",\"name\":\"Acquisition d'Actions Ordinaires de Cannara Biotech Inc. - Cannara Biotech\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#website\"},\"datePublished\":\"2022-09-01T04:01:00+00:00\",\"dateModified\":\"2026-04-07T06:00:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2022\\\/09\\\/01\\\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2022\\\/09\\\/01\\\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/2022\\\/09\\\/01\\\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acquisition d&#8217;Actions Ordinaires de Cannara Biotech Inc.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/\",\"name\":\"Cannara Biotech\",\"description\":\"Premium Quality Cannabis\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#organization\",\"name\":\"Cannara Biotech\",\"url\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cannara.ca\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/Cannara_LogoV1_500pxT.png\",\"contentUrl\":\"https:\\\/\\\/www.cannara.ca\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/Cannara_LogoV1_500pxT.png\",\"width\":500,\"height\":135,\"caption\":\"Cannara Biotech\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/#\\\/schema\\\/person\\\/3aaaabd90bd805cac77b57ae47bf0f91\",\"name\":\"cannaraadmin\",\"sameAs\":[\"https:\\\/\\\/www.cannara.ca\"],\"url\":\"https:\\\/\\\/www.cannara.ca\\\/fr\\\/author\\\/cannaraadmin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acquisition d'Actions Ordinaires de Cannara Biotech Inc. - Cannara Biotech","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cannara.ca\/fr\/2022\/09\/01\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\/","og_locale":"fr_FR","og_type":"article","og_title":"Acquisition d'Actions Ordinaires de Cannara Biotech Inc. - Cannara Biotech","og_description":"MONTREAL, QU\u00c9BEC \u2013 01 sept, 2022\u2013 Cannara&nbsp;Biotech&nbsp;Inc.&nbsp;(\u00ab&nbsp;Cannara&nbsp;\u00bb&nbsp;ou la&nbsp;\u00ab&nbsp;Soci\u00e9t\u00e9&nbsp;\u00bb) (TSXV:&nbsp;LOVE) (OTCQB: LOVFF) (FRA: 8CB), un producteur verticalement int\u00e9gr\u00e9 de cannabis et de produits d\u00e9riv\u00e9s de qualit\u00e9 sup\u00e9rieure qui poss\u00e8de l&rsquo;une des plus grandes installations pour la culture de cannabis int\u00e9rieure au&nbsp;Canada&nbsp;et la plus grande au Qu\u00e9bec, a annonc\u00e9 que le 31 ao\u00fbt 2022,&nbsp;Derek Stern, un administrateur [&hellip;]","og_url":"https:\/\/www.cannara.ca\/fr\/2022\/09\/01\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\/","og_site_name":"Cannara Biotech","article_published_time":"2022-09-01T04:01:00+00:00","article_modified_time":"2026-04-07T06:00:21+00:00","author":"cannaraadmin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"cannaraadmin","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cannara.ca\/fr\/2022\/09\/01\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\/#article","isPartOf":{"@id":"https:\/\/www.cannara.ca\/fr\/2022\/09\/01\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\/"},"author":{"name":"cannaraadmin","@id":"https:\/\/www.cannara.ca\/fr\/#\/schema\/person\/3aaaabd90bd805cac77b57ae47bf0f91"},"headline":"Acquisition d&rsquo;Actions Ordinaires de Cannara Biotech Inc.","datePublished":"2022-09-01T04:01:00+00:00","dateModified":"2026-04-07T06:00:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cannara.ca\/fr\/2022\/09\/01\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\/"},"wordCount":830,"publisher":{"@id":"https:\/\/www.cannara.ca\/fr\/#organization"},"articleSection":["Communiqu\u00e9s de presse"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.cannara.ca\/fr\/2022\/09\/01\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\/","url":"https:\/\/www.cannara.ca\/fr\/2022\/09\/01\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\/","name":"Acquisition d'Actions Ordinaires de Cannara Biotech Inc. - Cannara Biotech","isPartOf":{"@id":"https:\/\/www.cannara.ca\/fr\/#website"},"datePublished":"2022-09-01T04:01:00+00:00","dateModified":"2026-04-07T06:00:21+00:00","breadcrumb":{"@id":"https:\/\/www.cannara.ca\/fr\/2022\/09\/01\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cannara.ca\/fr\/2022\/09\/01\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.cannara.ca\/fr\/2022\/09\/01\/cannara-organisera-une-webdiffusion-destinee-aux-investisseurs-le-19-fevrier-2026-41\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cannara.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Acquisition d&#8217;Actions Ordinaires de Cannara Biotech Inc."}]},{"@type":"WebSite","@id":"https:\/\/www.cannara.ca\/fr\/#website","url":"https:\/\/www.cannara.ca\/fr\/","name":"Cannara Biotech","description":"Premium Quality Cannabis","publisher":{"@id":"https:\/\/www.cannara.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cannara.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.cannara.ca\/fr\/#organization","name":"Cannara Biotech","url":"https:\/\/www.cannara.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cannara.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.cannara.ca\/wp-content\/uploads\/2024\/10\/Cannara_LogoV1_500pxT.png","contentUrl":"https:\/\/www.cannara.ca\/wp-content\/uploads\/2024\/10\/Cannara_LogoV1_500pxT.png","width":500,"height":135,"caption":"Cannara Biotech"},"image":{"@id":"https:\/\/www.cannara.ca\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.cannara.ca\/fr\/#\/schema\/person\/3aaaabd90bd805cac77b57ae47bf0f91","name":"cannaraadmin","sameAs":["https:\/\/www.cannara.ca"],"url":"https:\/\/www.cannara.ca\/fr\/author\/cannaraadmin\/"}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/posts\/2698","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/comments?post=2698"}],"version-history":[{"count":0,"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/posts\/2698\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/media?parent=2698"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/categories?post=2698"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cannara.ca\/fr\/wp-json\/wp\/v2\/tags?post=2698"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}